Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 63, Issue 21
Displaying 1-28 of 28 articles from this issue
ORIGINAL ARTICLES
  • Shotaro Okanoue, Hiroyuki Sakae, Kenji Yokota, Takehiro Tanaka, Yuka O ...
    2024 Volume 63 Issue 21 Pages 2875-2884
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Objective Although the characteristics of Helicobacter pylori infection have been extensively reported, there is a lack of consensus regarding its characteristics in young adults. The present study examined the endoscopic and histological characteristics of young adults who underwent eradication therapy for H. pylori infection.

    Methods We examined the H. pylori infection status of first-year students at Okayama University School of Medicine and Dentistry between 2014 and 2020. A total of 152 (6.8%) students who were positive for H. pylori antibody or pepsinogen tests were enrolled in the study. Among them, 107 students underwent endoscopy, and their biopsy samples were investigated. Seventy-five students were diagnosed with H. pylori infections.

    Results Of 75 H. pylori-positive patients, 57 (76.0%) had endoscopic atrophic gastritis, and 42 (56.0%) had histological atrophy. A few patients had severe atrophic gastritis. All 65 patients who underwent an eradication assessment were successfully treated. After successful eradication, 26 patients underwent endoscopic follow-up. The mean follow-up period was 32.9 months. A histological evaluation revealed that gastric antrum atrophy had subsided in 11 of 14 patients, and atrophy in the lesser curvature of the gastric body had subsided in 7 of 8 patients.

    Conclusion More than half of young adults with H. pylori infection had atrophic gastritis. We found mild atrophy in young adults, which subsided shortly after eradication treatment. This study provides a foundation for future studies to evaluate the validity of eradication therapy in preventing gastric cancer in patients.

    Download PDF (731K)
  • Kiyoshi Iida, Masakazu Matsuzaki, Osamu Saito, Naoya Matsumoto
    2024 Volume 63 Issue 21 Pages 2885-2893
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: February 12, 2024
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective Exercise therapy as part of cardiac rehabilitation is one of the most effective treatments for patients with chronic heart failure (HF). The anaerobic threshold (AT) determined by an exhaled gas analysis during cardiopulmonary exercise testing (CPX) is used to prescribe the appropriate level of exercise therapy. However, CPX using an exhaled gas analysis is not widely performed because of its cost, complexity, and the need for skilled staff. Therefore, a simpler and inexpensive method for determining AT without respiratory gas measurements is required in patients with HF. The present study elucidated the relationship between the AT determined by the CPX ventilatory method (CPX-AT) and the AT determined by cardiac acoustic biomarkers (CABs), which are measured by acoustic cardiography (CAB-AT), in HF patients.

    Methods Patients underwent symptom-limited ramp CPX twice using a cycle ergometer. The ATs determined from the exhaled gas analysis were identified by three independent physicians. CABs, including the first heart sound (S1) and the second heart sound intensities (peak-to-peak amplitudes), electromechanical activation time (EMAT) defined as the time interval from the Q wave onset on electrocardiography to S1, heart rate, and other parameters, were collected during CPX.

    Patients Forty patients with HF were included in this study.

    Results A significant correlation (R=0.70; p<0.001) was found between CPX-AT and CAB-AT, using the double product of S1 intensity and heart rate. CAB-AT using S1 intensity also showed a significant correlation with CPX-AT (R=0.71; p<0.001).

    Conclusion The present study suggests a possible new method for determining AT without respiratory gas measurements in patients with HF.

    Download PDF (1451K)
  • Takayuki Katayama, Kae Takahashi, Osamu Yahara, Issei Matsuura, Yasuyu ...
    2024 Volume 63 Issue 21 Pages 2895-2901
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 11, 2024
    JOURNAL OPEN ACCESS

    Objective We aimed to investigate the relationship between tortuosity of the extracranial internal carotid artery (ICA) or vertebral artery (VA) and vascular risk factors among residents of Asahikawa, northeast Japan.

    Methods We retrospectively surveyed participants of "brain dock" medical brain checkups, which involved magnetic resonance imaging and angiography. We measured the tortuosity of the ICA and VA, and evaluated vascular risk factors based on medical interviews, questionnaires, and medical records.

    Results A total of 218 participants were enrolled in the study. ICA tortuosity (right and left) was significantly correlated with age [odds ratio (OR): 2.452, 95% confidence interval (CI): 1.695-3.548, p<0.001]. A more pronounced correlation was observed in females than in males (OR: 1.678, 95% CI: 1.004-2.807, p=0.048). VA tortuosity (right and left) was significantly correlated with age (OR: 1.786, 95% CI: 1.250-2.550, p=0.001) and smoking history (OR: 2.140, 95% CI: 1.235-3.707, p=0.007), and was more pronounced in females than in males (OR: 1.864, 95% CI: 1.107-3.137, p=0.019).

    Conclusion ICA tortuosity was correlated with age, while VA tortuosity was correlated with age and smoking history. ICA and VA tortuosity were more pronounced in females than in males.

    Download PDF (218K)
  • Monami Tarisawa, Masaaki Matsushima, Akihiko Kudo, Ken Sakushima, Yasu ...
    2024 Volume 63 Issue 21 Pages 2903-2912
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 18, 2024
    JOURNAL OPEN ACCESS

    Objective In 2022, Wenning et al. proposed the Movement Disorder Society Criteria (MDS criteria) for the Diagnosis of Multiple System Atrophy (MSA). These criteria were expected to provide useful alternatives to the second consensus statement. We examined trends in these diagnostic criteria.

    Methods We used patient data registered with the Hokkaido Rare Disease Consortium for Multiple System Atrophy, which has been recruiting patients with MSA through medical facilities in Hokkaido since November 2014. Patients were evaluated according to the MDS criteria based on neurological examinations and imaging findings at three separate times: the first evaluation, the time of enrollment (diagnosis), and the most recent evaluation (final evaluation).

    Results The MDS criteria were examined in 68 of 244 patients enrolled between November 2014 and July 2022. At the initial evaluation, the classifications were as follows: clinically established (n=27; 39.7%); clinically probable (n=13; 19.1%); possible prodromal (n=12; 17.6%); and negative [did not meet criteria (n=16; 23.5%)]. At the time of diagnosis, the classifications were as follows: clinically established (n=45; 66.2%); clinically probable (n=12; 17.6%); possible prodromal (n=4; 5.9%); and negative (n=7; 10.3%). At the final evaluation, the classifications were as follows: clinically established (n=52; 76.5%); clinically probable (n=9; 13.2%); possible prodromal (n=2; 2.9%); and negative (n=5; 7.4%).

    Conclusion We were able to clarify the changes in the criteria values and transition of patients due to the clarification of imaging and supportive findings in the MDS criteria.

    Download PDF (566K)
  • Nao Hanaki, Ryoto Sakaniwa, Takuhiro Moromizato, Jun Miyata, Keiko Ish ...
    2024 Volume 63 Issue 21 Pages 2913-2922
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 18, 2024
    JOURNAL OPEN ACCESS
    Supplementary material

    Objective Seasonal influenza affects healthcare demand. However, the efficacy of anti-influenza drugs, particularly among young patients at a low risk of complications, has rarely been evaluated. Therefore, we evaluated the efficacy of anti-influenza drugs against seasonal influenza in healthy young and middle-aged adults.

    Methods A systematic review and network meta-analysis were conducted. The Cochrane Central Register of Controlled Trials and Medical Literature Analysis and Retrieval System Online were searched for original articles reporting double-blind, randomized controlled trials published up to the end of July 2023. Clinical trials that tested the efficacy of anti-influenza drugs in young and middle-aged patients with seasonal influenza were also included. The primary outcome was time to fever alleviation. The efficacy and adverse effects of these treatments were estimated using a Bayesian hierarchical random-effects model and a Markov chain Monte Carlo simulation.

    Results In total, 24 articles with 34 treatments and 8,949 individuals were included. Oseltamivir (300 mg/day for 5 days) showed the largest reduction in time to fever alleviation by -19.1 [95% confidence interval (CI): -29.4, -10.7] h compared with a placebo. Baloxavir marboxil (40 mg/day) reduced the time to symptom alleviation by -28.2 (95% CI: -42.7, -13.7) h, and peramivir (300 mg/day) administered by intravenous infusion for 1 day reduced the time to resumption of usual activities by -43.5 (95% CI: -72.8, -14.2) h.

    Conclusion Several pharmaceutical treatments were able to reduce the recovery time for fever and symptom alleviation and resumption of usual activities in young and middle-aged adults with seasonal influenza without increasing the risk of complications.

    Download PDF (404K)
CASE REPORTS
  • Shun Sasaki, Kazuhiro Ota, Taro Iwatsubo, Noriaki Sugawara, Akitoshi H ...
    2024 Volume 63 Issue 21 Pages 2923-2927
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS
    Supplementary material

    A 70-year-old man who had undergone treatment for gastroesophageal reflux disease (GERD) by a family doctor presented to our hospital with severe heartburn and dysphagia despite taking vonoprazan (20 mg) for 3 months. A diagnosis of vonoprazan-refractory nonerosive reflux disease was made based on esophagogastroduodenoscopy and esophageal function examinations. The patient elected to undergo endoscopic treatment for GERD. Therefore, we performed endoscopic treatment using the endoscopic submucosal dissection (ESD-G) technique developed at our institution. After endoscopic treatment, his GERD symptoms disappeared and he no longer required GERD-related medications. An examination of his esophageal function revealed the improvement of items related to GERD.

    Download PDF (642K)
  • Hiroki Sato, Shozaburo Fujii, Tetsuhiro Okada, Hidemasa Kawabata, Yuki ...
    2024 Volume 63 Issue 21 Pages 2929-2937
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    A woman in her 60s presented with a small pancreatic head tumor. Imaging studies revealed a 13-mm well-defined pancreatic head tumor. A neuroendocrine neoplasm was suspected, and the patient opted for observation at that time. After 8 months, the patient began experiencing sweating while fasting, and blood tests during regular follow-up visits showed hypoglycemia. Hypoglycemia was induced during fasting test. The tumor exhibited clear features of an insulinoma during follow-up observation. While small neuroendocrine neoplasms are often managed through observation, caution should be exercised regarding their transformation into functional neuroendocrine tumors.

    Download PDF (2481K)
  • Sotaro Ozaka, Ryusuke Soma, Haruhiko Takahashi, Yuta Shimomori, Masahi ...
    2024 Volume 63 Issue 21 Pages 2939-2942
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 11, 2024
    JOURNAL OPEN ACCESS

    A 35-year-old man with fever and diarrhea visited our hospital because of white string-like fecal excretion. Based on a morphological examination of the excreted object, a Diphyllobothrium infection was suspected. Additionally, Gram staining of a fecal sample revealed Campylobacter infection. After the intraduodenal administration of meglumine/diatrizoate sodium, the tapeworm was excreted. A polymerase chain reaction-based DNA sequence analysis demonstrated that the tapeworm excreted in this case was Diphyllobothrium nihonkaiensis. This report presents a rare case of coinfection with Diphyllobothrium nihonkaiensis and Campylobacter jejuni. Therefore, it is important to consider the coexistence of other intestinal infections when diagnosing parasitic infections in patients with fever.

    Download PDF (808K)
  • Mitsuhito Koizumi, Sho Ishikawa, Kaori Marui, Masahito Kokubu, Yusuke ...
    2024 Volume 63 Issue 21 Pages 2943-2947
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: February 26, 2024
    JOURNAL OPEN ACCESS

    A 70-year-old woman presented with stage III pancreatic head cancer. After endoscopic sphincterotomy, a fully covered self-expandable metallic stent (FCSEMS) was placed in the common bile duct to manage jaundice. The patient developed a fever and abdominal pain 40 days after stent placement, with a suspected diagnosis of infected pancreatic pseudocyst. Purulent discharge from the papilla was observed during FCSEMS removal, and pancreatography revealed a pseudocyst connected to the main pancreatic duct. The pancreatic pseudocyst resolved after transpapillary drainage. Pancreatic pseudocysts should be suspected after biliary FCSEMS placement, and prompt removal and endoscopic drainage of the FCSEMS should be considered.

    Download PDF (3476K)
  • Misa Yuuki, Kotaro Kurasaki, Mariko Murata, Mizusa Matsuda, Yusuke Hat ...
    2024 Volume 63 Issue 21 Pages 2949-2952
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: September 04, 2024
    JOURNAL OPEN ACCESS

    The co-occurrence of subacute thyroiditis (SAT) and Graves' disease (GD) is rare. A 62-year-old Japanese man presented with shifting neck pain and elevated thyroid hormone level. The patient tested positive for thyroid-stimulating hormone receptor antibodies. Additionally, thyroid hormone levels did not decrease during treatment with prednisolone for SAT. Consequently, concurrent GD was suspected, and diagnostic assistance was obtained by confirming increased uptake on 99mTechnetium thyroid scintigraphy. A genetic analysis of human leukocyte antigen (HLA) revealed genotypes associated with susceptibility to SAT (HLA-B*35:01) and GD (HLA-DPB1*05:01). Furthermore, the possibility of coronavirus disease 2019 as a related environmental factor cannot be ruled out in this case.

    Download PDF (609K)
  • Shogo Funakoshi, Mitsuru Nishiyama, Masahiro Komori, Masamitsu Hyodo, ...
    2024 Volume 63 Issue 21 Pages 2953-2959
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 11, 2024
    JOURNAL OPEN ACCESS

    A 59-year-old man was admitted to our hospital with hyponatremia. An endocrine examination indicated panhypopituitarism, and magnetic resonance imaging revealed a mass-like lesion in the pituitary gland. Sinus endoscopy revealed a fungal mass in the sphenoid sinus, and the patient was diagnosed with hypopituitarism due to aspergillosis of the central nervous system (CNS). The patient's hyponatremia resolved with hydrocortisone replacement. Although the right internal carotid artery was eventually occluded, antifungal medications were administered for the aspergillosis, and the patient's general condition improved. The patient's CNS lesions have remained under control since discharge. This is the first case to suggest that ACTH secretion may be relatively preserved in Aspergillus-induced hypopituitarism.

    Download PDF (782K)
  • Nobuaki Ozaki, Yuri Hayashi, Atsushi Kiyota
    2024 Volume 63 Issue 21 Pages 2961-2964
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 11, 2024
    JOURNAL OPEN ACCESS

    Hereditary coproporphyria (HCP) is caused by a partial deficiency of coproporphyrinogen oxidase during heme biosynthesis. Givosiran is approved for the treatment of acute hepatic porphyria. We herein report the case of a 47-year-old woman with HCP. Monthly givosiran administration improved her subjective symptoms and reduced her δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) levels to the normal range. However, givosiran was discontinued after six months due to a decreased renal function. The patient's ALA and PBG levels remained within the normal ranges, and her HCP-related symptoms resolved more than 2 years after the discontinuation of givosiran.

    Download PDF (141K)
  • Masato Mizuta, Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Masayu ...
    2024 Volume 63 Issue 21 Pages 2965-2970
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: February 01, 2024
    JOURNAL OPEN ACCESS

    A 37-year-old man with autosomal dominant polycystic kidney disease (ADPKD) was admitted to our hospital with a liver volume of 8,000 cm3. Hepatic arterial embolization was performed using a microcoil but was ineffective. Eight years later, the hepatomegaly progressed to liver failure and death. At autopsy, the liver weighed 21.5 kg, and the entire liver had been replaced by cysts; in the few remaining areas of liver parenchyma, microscopic, small cysts of various sizes and fibrosis were evident, with only a few normal hepatocytes observed. Hepatic arterial branches developed; however, the portal vein could not be observed.

    Download PDF (2831K)
  • Suzuka Matsuoka, Keiichi Fujiwara, Yuki Takigawa, Saki Ito, Sho Mitsum ...
    2024 Volume 63 Issue 21 Pages 2971-2976
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 25, 2024
    JOURNAL OPEN ACCESS

    A 70-year-old woman with anti-aminoacyl-tRNA synthetase (ARS) antibody-positive interstitial lung disease (ARS-ILD) received daily medications and regular cyclophosphamide cycles for recurring exacerbations. Approximately four years after immunosuppression initiation, the patient was admitted for progressive dyspnea on exertion. Chest computed tomography (CT) findings were suggestive of acute exacerbation. Despite intensified immunosuppressive treatment, the radiographic findings worsened, and serum Krebs von den Lungen-6 (KL-6) levels increased. A bronchoalveolar lavage fluid (BALF) examination revealed amorphous globules and alveolar macrophages with eosinophilic granules. Owing to negative anti-granulocyte-macrophage colony-stimulating factor antibody tests, a diagnosis of secondary pulmonary alveolar proteinosis (PAP) was established.

    Download PDF (2521K)
  • Takuya Terakawa, Yuya Hayasaka, Yuka Umeki, Mako Ikeda, Yoshiki Matsuo ...
    2024 Volume 63 Issue 21 Pages 2977-2981
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 11, 2024
    JOURNAL OPEN ACCESS

    Vascular occlusive events are notable adverse effects of tyrosine kinase inhibitors (TKIs), which are promising treatments for chronic myeloid leukemia (CML). We herein report the case of a patient with CML who developed cerebrovascular occlusion of the circle of Willis during TKI treatment. Our patient did not meet the diagnostic criteria for moyamoya disease due to the insignificant development of moyamoya vessels. The lack of moyamoya vessel development may be explained by the suppression of tyrosine kinases that are responsible for angiogenesis. Cerebrovascular occlusion of the circle of Willis, without significant development of moyamoya vessels, may be an important phenotype of TKI-associated vasculopathy.

    Download PDF (1183K)
  • Yosuke Takeuchi, Teruaki Masuda, Noriyuki Kimura, Takeshi Mizukami, Ka ...
    2024 Volume 63 Issue 21 Pages 2983-2986
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: August 28, 2024
    JOURNAL OPEN ACCESS

    Multiple system atrophy (MSA) is a progressive neurodegenerative disease that often causes vocal cord paralysis (VCP), Parkinsonism, cerebellar ataxia, and autonomic dysfunction. VCP is the most fatal symptom that affects the prognosis of patients with MSA. Coronavirus disease 2019 (COVID-19) is often associated with neurological complications and it has recently been reported to induce VCP in patients without neurodegenerative diseases. We herein present two cases of patients with MSA in whom VCP worsened after COVID-19 and this led to the need to perform emergency tracheostomies. As VCP may deteriorate after COVID-19 in patients with MSA, it is important to prevent COVID-19 in these patients and closely monitor such patients for any signs of VCP deterioration post-infection to improve their prognosis.

    Download PDF (879K)
  • Koji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, Shuntaro Saito, Jun Kik ...
    2024 Volume 63 Issue 21 Pages 2987-2990
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Sjögren's syndrome (SS) can present with extraglandular organs, such as interstitial lung disease (ILD). Anti-SS-A antibody is frequently found in SS cases, whereas anti-centromere antibody (ACA) is detected in some SS cases. Notably, the anti-SS-A and ACA double-positive cases exhibited distinct features with a higher prevalence of ILD. However, there have so far been no reports on the treatment of ILD in anti-SS-A and ACA double-positive cases. We herein present a case of ILD with anti-SS-A and ACA double-positive SS that was successfully treated with immunosuppressive therapy. Our case suggests the potential efficacy of immunosuppressive therapy for this poorly understood condition.

    Download PDF (372K)
  • Koji Suzuki, Mitsuhiro Akiyama, Yasushi Kondo, Katsuya Suzuki, Yuko Ka ...
    2024 Volume 63 Issue 21 Pages 2991-2994
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 04, 2024
    JOURNAL OPEN ACCESS

    Rosai-Dorfman disease (RDD) is a rare histiocytic proliferative disorder characterized by lymphadenopathy and extra-nodal manifestations. Some patients with RDD require systemic treatment, but there is no consensus on the treatment strategy owing to its extreme rarity. Overexpression of tumor necrosis factor α (TNF-α) has been reported in lesions of patients with RDD and is thought to be involved in its pathogenesis. We herein report the first case of RDD with cutaneous involvement and arthritis that was successfully treated with methotrexate and infliximab. This case highlights the potential efficacy of anti-TNF-α therapy for RDD, offering a novel treatment option for this rare condition.

    Download PDF (988K)
  • Kemmyo Sugiyama, Toru Tsuboya, Seitaro Nakagawa, Toshihiro Kikuchi, Yu ...
    2024 Volume 63 Issue 21 Pages 2995-2999
    Published: November 01, 2024
    Released on J-STAGE: November 01, 2024
    Advance online publication: March 25, 2024
    JOURNAL OPEN ACCESS

    Home healthcare is important for allowing patients to live their lives. However, home-care bedridden patients often experience pressure ulcers in the lower extremities, which can lead to life-threatening infections requiring decisions on the need for amputation. We herein report a patient with an infected lower-limb pressure ulcer with a history of spinal injury. The patient, his family, and the home-care physician repeatedly shared decision-making to deliver home-based treatment instead of amputation. Administration of wound dressing, AQUACEL® Ag, led to complete epithelialization. Such shared decision-making and dressing were feasible in a home-care setting and broadened its scope.

    Download PDF (476K)
PICTURES IN CLINICAL MEDICINE
LETTERS TO THE EDITOR
ERRATUM
feedback
Top